https://www.selleckchem.com/products/pu-h71.html
The device showed its immune protection properties by preventing formation, by the rat recipient, of antibodies against encapsulated allogenic islets. Injection of a rat beta cell line into the device normalized fasting glycemia of diabetic rat with retrieval of viable cell clusters after 2 months. These data suggest that MailPan® constitutes a promising encapsulation device for widespread use of cell therapy for type 1 diabetes.Recent studies have shown that dietary patterns confer protection from certain chronic diseases related to oxi
Like
Comment
Share
